GSD type IB is characterized by the clinical features of glucosetion was investigated in two patients with glycogen storage 6-phosphatase deficiency (GSD type IA), including hepatomegdisease type IB and neutropenia. Glycogen storage disease aly, growth retardation, fasting hypoglycemia, and lactic acidosis, type IB was documented by liver biopsy and a normal but normal latent enzymatic activity in the liver (l,2). Biochemamount of latent glucose-6-phosphatase activity. Patient A ical studies have demonstrated a defect in the microsomal transhad stomatitis, skin infections, and septicemia; patient B port system for G6P in GSD type IB (2, 3). Recurrent infection had respiratory infections, periodontitis, and oral candidi-occurs more prominently in type IB, and neutropenia is another asis. Absolute neutrophil counts ranged from 114 to 25801 distinguishing feature of this type (4, 5). Studies of PMN migramm3. Diminished and delayed migration of PMN into a tion in a patient with GSD type IB and neutropenia indicated skin "window" occurred in B. Random and directed PMN impaired PMN mobilization in vivo and impaired random and migration under agarose toward f-Met-Leu-Phe, pepstatin directed PMN migration in vivo (I). We have further investigated A, and zymosan-activated serum were severely diminished PMN function in two patients and demonstrated abnormalities in both patients. At lo-' M f-Met-Leu-Phe, mean random in metabolic and bactericidal functions as well as motility.
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MATERIALS AND METHODS
Informed consent was obtained from the parents for all studies. Fresh liver tissue and patients' PMN were fixed in 1.5% glutaraldehyde for electron microscopy.
Leukocyte migration in vivo was studied by the dermal abrasion method of Rebuck and Crowley (7) and by epinephrine stimulation (8) . Following subcutaneous injection of 0.3 ml epinephrine, leukocyte counts and differentials were obtained at 0, 5, 10, 15, 30, and 60 min.
In vitro studies. Venous blood was collected in syringes containing 20 U heparin per ml of blood, and PMN were isolated and collected by Dextran gravity sedimentation, as previously described (9) . PMN migration in vitro was studied under agarose according to the method of Nelson et al. (10) . In each migration assay, patients' PMN were run simultaneously with control PMN on the same agarose plate. A 10-p1 aliquot, containing 2.5 x lo5 PMN, was placed in the center well of each three well series. Ten pl of chemoattractant was placed in the outermost well, and 10 p1 of buffer (phosphate-buffered saline) in the inner well. Chemoattractants, including FMLP (Sigma), pepstatin A" (Sigma), and zymosan (Sigma) activated serum were utilized at maximally effective concentrations. Plates were incubated at 37" C in a humidified 5% COz atmosphere for 2 h, unless otherwise specified, and examined under a B/L Trisimplex projection microscope at 2 . 5~ magnification. Results were expressed as total migration in cm from the well by the leading front. Each patients' migration was compared to his own control migration and expressed as percent of the control. When multiple assays at the same chemoattractant concentration were performed, Student's paired t test for dependentlindependent variables was used as a test for statistical significance.
Spectrophotometric quantitation of NBT reduction was measured as previously described (12) . PMN bactericidal activity was assessed by the method of Douglas et al. (13) . PMN H202 generation was measured by a modification of the method of Root et al. (14) .
RESULTS
In vivo studies. PMN morphology under light and electron microscopy was normal in both patients. Table 1 presents observations of in vivo granulocyte mobilization in both patients. A granulocytosis was seen with fever postoperatively on one occasion in patient A, ANC rising to >4000/mm3. On most other occasions, ANC remained low even during serious infections. In patient B, ANC increased from 490 to 1240/mm3 10 min after epinephrine stimulation, indicating the presence of a normal marginating granulocyte pool that was not preferentially entrapped in the vasculature. Results of a Rebuck skin "window" experiment in patient B are presented in Table 2 , revealing diminished and delayed migration of PMNs into the abrasion site.
In vitro studies. Results of PMN migration experiments are summarized in Table 3 . Random and directed PMN migration under agarose toward FMLP, pepstatin A, and zymosan-activated serum were diminished in both patients. The mean random migration of PMN was 64% of control for patient A ( n = 12) and 42% of control for patient B ( n = 22). The "leading front"
directed migration values for various chemoattractants ranged t Serial leukocyte counts and smears were obtained in a patient (B) with glycogenosis IB and neutropenia following subcutaneous injection of 0.3 ml epinephrine.
from 15 to 57% of control for patient A and 4 to 57% of control for patient B. In contrast, random and directed migration in a patient with chronic neutropenia and a patient with GSD type I11 were normal (Table 3) . Parents' PMN migration was normal (data not shown). No cell directed inhibitors or chemotactic factor inactivators were present in patients' sera, and zymosan activation effected normal control PMN migration (data not shown). Figure 1 presents the results of dose-response experiments which revealed diminished random and directed PMN migration over a 2 log range of chemoattractant concentration. Patients' random and directed migration were similar to control random migration over the entire range of FMLP concentration studied. Figure 2 demonstrates the PMN migration in B was also severely impaired with prolonged chemoattractant incubation up to 6 h. These experiments demonstrate that the defect in PMN migration was independent of chemoattractant concentration and incubation time. Table 4 represents the results of latex stimulated quantitative NBT reduction. The patients' PMN had diminished NBT reduction, with a AOD of 0.055 for patient A compared to 0.16 for control and a AOD of 0.11 for patient B compared to 0.17 for control. In contrast, a patient with chronic neutropenia and a patient with GSD type I11 had normal NBT reduction.
PMN bactericidal activity with Escherichia coli is presented in Figure 3 . Patient B had a significant defect with <0.2 log killing at 2 h; patient A had a mild reduction with approximately 0.67 log killing at 2 h.
Parents' PMN had normal NBT reduction and bactericidal activity (data now shown).
H202 generation in PMNs (of 1.56 x lo5 cells/reaction mixture) was evaluated using latex beads and phorbol 12-myristate 13-acetate as stimulants. The H202 was measured by the extinction of fluorescence of scopoletin during its oxidation by horseradish peroxidase in resting and stimulated cells. The results were expressed as the percent of relative fluorescence, and it was observed that patient B and control resting values were 93 and 98%, respectively. The phorbol 12-myristate 13-acetate-stimulated values for the patient was 78% which is diminished as compared to 49% for the control value. The latex stimulated cells of patient B did not show any difference when compared to control. t Total number of cells in 10 fields of a 10-mm grid.
$ Not done. Table 3 . Neutrophil chemotaxis*, t * Each value represents mean of three samples, expressed in units of OD at 5 15 nm. Sample size for patient A and control A equal to 1.5 x lo6 PMN; all other samples equal to 2.5 X lo6 PMN.
DISCUSSION
Our study demonstrates abnormal PMN function in two patients with GSD type IB, with defects in motility, NBT reduction, and bactericidal activity. These results suggest a basis for the association of GSD type IB with recurrent infections and neutropenia previously recognized ( 1, 15, 16) , and further characterize the defect in PMN migration reported by other investigators (1, (17) reported impaired random and directed PMN migration in one patient with GSD type IB and neutropenia who suffered from recurrent staphylococcal infections. Our dose-response and kinetic studies demonstrate that the impaired migration is independent of incubation time and chemoattractant concentration.
The observation of impaired random PMN migration indicates an intrinsic defect in PMN motility. This observation is consistent with that reported by Anderson et al. (17) who documented impaired neutrophil motility and impaired redistribution of surface adhesion sites. Our patients differ from their patient, however, in that the latter had normal intracellular killing of staphylococci in vitro, despite a history of severe recurrent staphylococcal infections, whereas our patients had diminished bactericidal activity with E. coli. This difference may reflect heterogeneity of PMN function among individual patients. The difference may also be related to technical factors in that isolated PMNs with E. coli at a bacteria/PMN ratio of 8: 1 were used in our studies whereas Anderson et a[. (17) used a whole blood assay for killing with Staphylococcus aureus at a bacteria/PMN ratio of 50: 1. Since bactericidal activity and phagocytosis-associated chemiluminescence were normal, Anderson et al. (17) concluded that the neutrophil disorder in GSD type IB was restricted to motility and locomotion. In contrast, our results suggest a more generalized neutrophil defect, affecting intrinsic motility, chemotaxis, and perhaps phagocytosis.
G6P of liver and kidney is a multicomponent, membranebound enzyme system of the endoplasmic reticulum (2) . This system involves transport of the substrate, G6P, from the cytoplasm into the cisternae of the endoplasmic reticulum, hydrolysis on the luminal surface of the membrane, and eMux of inorganic phosphate out of the cisternae (2, 3, 17) . A deficiency of this enzyme system causes type I GSD. There are two forms of the disease: type IA, the more common form, in which little or no G6P activity is detected in liver, kidney, or small intestine; and type IB, or pseudotype I, in which patients with similar clinical findings appear to have normal G6P activity. Lange et al. (2) demonstrated that this so-called "functional deficiency" of the enzyme in type IB is due to a defect in the G6P transport moiety of the enzyme. As a result of this defect in G6P transport, G6P activity in fresh, unfrozen liver tissue in GSD type IB is low. The activity is normal, however, if frozen liver tissue is used for the assay, as is ordinarily done with biopsy material. Freezing or detergent action disrupts the microsomal membrane such that G6P transport is not necessary. A defect of the G6P transport system of the microsomal membrane in hepatocytes is the biochemical defect in GSD type IB.
The mechanism responsible for abnormal PMN function in GSD type IB is not known. If the metabolic defect found in hepatocytes in GSD type IB is also present in analogous fashion in neutrophils, it would result in a block of G6P transport from the cytosol into the endoplasmic reticulum of the PMN. G6P concentration is important in PMN chemotaxis, the hexose monophosphate shunt, and phagocytosis. Stossel et al. (19) showed that there was a marked acceleration of glycogen breakdown in guinea pig peritoneal PMNs phagocytizing latex particles in the absence of glucose; there was increased utilization of G6P, without changes in glycogen phosphorylase or glycogen synthetase activity or in levels of ATP, ADP, AMP, inorganic phosphate, or cyclic AMP. Earlier work by Beck (20) suggested that primary control of the phosphogluconate pathway in leukocytes depends upon the G6P concentration. Furthermore, G6P concentration is very important in chemotaxis as a substrate in anaerobic glycolysis, which provides the major source of energy for PMN chemotaxis (2 1). If a block of G6P transport is present in neutrophils in GSD type IB, as it is in hepatocytes, then these PMN functions may be affected.
Other studies of GSD type IB patients support the concept of a metabolic defect of G6P transport in the neutrophil. Heyne and Gahr (22) showed that PMN from a patient with GSD type IB had reduced respiration during Candida albicans-stimulated phagocytosis, compared to type IA patients and controls. Bartram et al. (16) suggested that this metabolic defect is not only responsible for altered oxygen consumption during phagocytosis, but also for other hematological changes. They suggested that the variability in severity of neutropenia observed in GSD type IB patients is related to variability in the activity of the 6 6 P translocase, and that the frequency and severity of bacterial infections parallels the neutrophil count. Narisawa et al. (3, 23) presented evidence in GSD type IB patients that supports this latter concept. Two siblings with persistent neutropenia, frequent infections, and severe hypoglycemic episodes had a complete defect in the G6P transport system as determined by enzyme latency (22) . In contrast, a third patient, an adult with no history of neutropenia or severe hypoglycemia, had a partial deficiency of the G6P transport system (24) . Finally, Seger et al. (25) demonstrated that impaired hexose monophosphate shunt activity and oxygen consumption in PMN from a patient with GSD IB was corrected by cell homogenization and the addition of exogenous NADPH, further supporting the concept of a defect of G6P transport in the neutrophil.
Our study confirms the previously recognized observation of abnormal PMN function in patients with GSD type IB and neutropenia, with defects in motility and chemotaxis. In addition, o;r results suggest a more generalized PMN defect, affecting motilitv and chemotaxis. NBT reduction. and bactericidal activity. ~h k mechanism responsible for abndrmal PMN function in GSD type IB is not known, but a defect of the G6P transport system of the microsomal membrane in hepatocytes is the biochemical defect in GSD type IB. If an analogous defect of G6P transport is present in neutrophils in GSD type IB, then PMN chemotaxis, hexose monophosphate shunt activity, and phagocytosis may be affected because these processes are dependent on G6P concentration. Other studies support this concept of a metabolic defect of G6P transport in the neutrophil in GSD type IB. The role of G6P transport in the neutrophil requires further investigation because it may be the basis for abnormal PMN function in GSD type IB.
